Table 2

Comparison of cognitive function between MMD and HCs after IQ controlled (covariance analysis)

HC (n=23）MMD (n=49)FP value
PM
TBPM12.30±2.7049.06±3.7618.339.005*
EBPM14.22±2.11012.14±3.2084.353.041*
Total scores26.52±3.86021.20±6.2328.424.005*
RBANS domains
IM87.43±11.31779.94±15.7150.4800.491
VB79.26±13.08475.49±10.0170.4730.494
VF94.04±8.93183.27±14.3194.431.039*
AT108.70±8.97793.76±15.6259.883.002**
RM90.04±10.22781.41±15.3811.1210.293
SS459.48±34.927413.86±53.0276.023.017*
TSIS88.57±8.72777.63±12.6675.916.018*
WCST
PE10.87±24.12512.10±24.6360.0220.881
CC4.74±1.9124.10±2.1140.0130.910

  • Data are given as mean±SD.

  • iBoldfaced values: If P value is lower than 0.05, boldfaced was used to discriminate.

  • *P<0.05, **P<0.01.

  • AT, attention; CC, category completed; EBPM, event-based prospective memory; HC, healthy control; IM, immediate memory; MMD, moyamoya disease; PE, perseverative error; PM, prospective memory; RBANS, Repeatable Battery for the Assessment of Neuropsychological Status; RM, retrospective memory; SS, scale score; TBPM, time-based prospective memory; TSIS, total scale of index scores; VB, visual breadth; VF, verbal fluency; WCST, Wisconsin Card Classification Test.